ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 22 filers reported holding ENZYMOTEC LTD in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,218,000 | +3068.6% | 187,170 | +1662.1% | 0.00% | – |
| Q4 2016 | $70,000 | +100.0% | 10,622 | +112.0% | 0.00% | – |
| Q3 2016 | $35,000 | -65.7% | 5,011 | -59.0% | 0.00% | – |
| Q2 2016 | $102,000 | -79.5% | 12,208 | -77.9% | 0.00% | – |
| Q1 2016 | $498,000 | +4.8% | 55,169 | +13.8% | 0.00% | – |
| Q4 2015 | $475,000 | +246.7% | 48,486 | +219.0% | 0.00% | – |
| Q3 2015 | $137,000 | +87.7% | 15,198 | +73.9% | 0.00% | – |
| Q2 2015 | $73,000 | +192.0% | 8,739 | +152.9% | 0.00% | – |
| Q1 2015 | $25,000 | -77.3% | 3,456 | -75.9% | 0.00% | – |
| Q4 2014 | $110,000 | +214.3% | 14,355 | +178.4% | 0.00% | – |
| Q3 2014 | $35,000 | +105.9% | 5,156 | +319.2% | 0.00% | – |
| Q2 2014 | $17,000 | -93.1% | 1,230 | -89.1% | 0.00% | – |
| Q1 2014 | $248,000 | -23.2% | 11,257 | -5.8% | 0.00% | – |
| Q4 2013 | $323,000 | – | 11,952 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 202,962 | $5,482,000 | 1.66% |
| Visium Asset Management, LP | 690,000 | $18,637,000 | 0.37% |
| ALYDAR PARTNERS LLC | 90,000 | $2,431,000 | 0.25% |
| Paulson & Co. | 1,733,030 | $46,809,000 | 0.23% |
| GILDER GAGNON HOWE & CO LLC | 218,232 | $5,894,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 83,971 | $2,268,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 10,000 | $270,000 | 0.04% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 5,450 | $148,000 | 0.03% |
| TFS CAPITAL LLC | 9,736 | $263,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 208,806 | $5,640,000 | 0.01% |